In this edition of the Straight Talk podcast, Mike Bertaut talks with Brice Mohundro, a clinical pharmacist at Blue Cross and Blue Shield of Louisiana, about the opioid epidemic in the United States.
“Did you know that health insurance companies that participate in federal or state programs also have stricter gross margin/profit caps on that business? For example, the Medicaid health plans in Louisiana have to pay state and local taxes, and they pay for all administration on 15 percent of the payments they get from the state for managing care of Medicaid patients.”
Drug Company Magic, Part 2
As we move further into 2017, I am increasingly concerned about the impact drug price increases have on your premiums. I’ve written before about the “magical” way drug companies arrive at their pricing.
The fastest-growing part of your health insurance premiums may not be immediately obvious to you. It’s not hospital costs or doctor’s costs or the cost of lab services, X-rays or surgeries. The answer is spellbinding…
By Michael Bertaut, Healthcare Economist
In Part 1 of this Blog on Hepatitis C, we looked at recent advancements in treatments and their costs, as well as the studies underway to determine how widespread the disease is. We learned that millions are infected, new prescription drugs are very effective and their costs sky-high.